Greenberg Traurig (GT) is proud to sponsor the 30th Annual ACI Drug & Medical Device Litigation Conference—the premier event for the Products Liability and MDL Defense Bar—taking place December 3–4 in New York City.
This conference brings together more than 400 pharmaceutical and medical device litigators, private practitioners, and judges to network and explore the latest strategies in multi-district litigation. Attendees will benefit from a content-rich program and sophisticated panel discussions that deliver real-world insights into the most critical international developments affecting drug and device product liability litigation.
On December 4, Cliff Merrell will participate in the panel, “Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation.” Also on December 4, Sydney Fairchild Williamson will speak on the panel, “Navigating Rule 702 Amendments: Strategies for Expert Testimony in Drug and Medical Device Litigation.”